Navigation Links
North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India
Date:11/27/2009

DURHAM, N.C., Nov. 27 /PRNewswire/ -- Cromoz Inc., located in Research Triangle Park, will initiate water-soluble carbon nanotube-based cancer drug delivery system in Hyderabad, India. The water-soluble carbon nanotubes, which have functional groups on the walls that allows for conjugation with cancer drugs, was developed in partnership with the Indian Institute of Kanpur (ITT). The conjugated carbon nanotubes serves as a drug delivery vehicle with the ability to target the cancer site which has the potential to increase the drug efficacy.

The target drug delivery reduces the amount of chemotherapeutic drugs used in cancer treatment and minimizes the side effects. The reduced dosage without compromising the drug efficacy will make the cancer treatment more potent and targeted to killing the cancer and more affordable and available to a larger community.

"Certain percentage of these carbon nanotubes are composed of smaller Quantum Carbon Dots," stated Iffat Allam, President & CEO of Cromoz Inc. "The nontoxic carbon quantum dots can be used as Fluorescent Probes for imaging living biological processes and to monitor cancer growth. These quantum dots are of assorted sizes, they absorb and emit light at different wavelengths. This results in multi-colored images which will be very useful to diagnose a specific organ and its function and the effect of drug delivery to specific cancer sites."

Cromoz has successfully conjugated cancer drugs such as Taxol and Gemcitabine and is currently working with Johns Hopkins Cancer Center in Maryland, USA. Early next year Cromoz will initiate a research and development (R&D) and manufacturing facility in Biotech Park in Hyderabad, India.

Cromoz Inc., is an advanced materials innovator and manufacturer focused on the development of carbon nanotechnology-enabled products primarily for the biomedical industry. These innovative products are based on two proprietary technologies, water-soluble carbon nanotubes and water-soluble fluorescent carbon quantum dots. The CNTs (Carbon Nano Tubes) are insoluble in water. Some have used a common technique to wrap the CNT with hydrophilic molecules to make them disperse in water. Cromoz have successfully derivatized the multi-wall of CNTs and Carbon Dots to make them water-soluble. These derivatized CNTs are bio-friendly, fluorescent and hence well suited for drug delivery. For more information, log on to http://www.cromoz.com.


Contact:

Anita L. Jackson, MD: 910-258-5480 or adocalj@aol.com
Mr. Ashfaq Hussein: 099-7122-1940 or info@cnanoz.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Cromoz Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India
2. North America automobile sector bottom of world sustainability league
3. North Highland Ranks in Top Five of Consulting Industrys Best Firms to Work For
4. Northeast Indiana Regional Partnership to Participate in 2009 Orthopedic Design & Technology Conference & Exhibition
5. Bionovo to Present on Novel Female-Specific Drugs for Obesity at the 20th Annual Meeting of the North American Menopause Society
6. Cord Blood America Announces Preferred Pricing for Blue Cross of Northeastern Pennsylvania Members
7. Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.
8. Avantium to Deliver Flowrence System to Pacific Northwest National Laboratory (PNNL), USA
9. Buehler Motor, Inc., Significantly Expands Customer and Partner Support in North America
10. Successful Field-Trial Remediation of 1,2-DCA and VC Contaminated Groundwater in Northern Italy
11. Leading North American Emergency Medical Services Provider British Columbia Ambulance Service Selects NICE Inform for Improved Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2016)... ... May 18, 2016 , ... Tech Coast Angels (TCA) today ... Cognition Therapeutics at the annual ACA Summit last week in Philadelphia. , ... of ACA’s member angel groups. It is the highest honor available for an early-stage ...
(Date:5/18/2016)... ... May 18, 2016 , ... ... are a direct result of asthma complications.* Costing more than $56 billion in ... , “For too many, the suffering associated with uncontrolled asthma ...
(Date:5/17/2016)... McKinney, Texas (PRWEB) , ... May 17, 2016 ... ... product for use in animal waste reduction applications, announced today it will be ... Des Moines, Iowa. , ManureMagic™ was featured in the Wall Street Journal last ...
(Date:5/17/2016)... , May 17, 2016 ... located in Basel, Switzerland ... oral inhibitor of P38 mitogen-activated protein kinase. ... Strekin will build the necessary research ... indications in which MAP Kinases play fundamental roles. ...
Breaking Biology Technology:
(Date:4/14/2016)... , April 14, 2016 ... and Malware Detection, today announced the appointment of ... the new role. Goldwerger,s leadership appointment comes ... the heels of the deployment of its platform at ... behavioral biometric technology, which discerns unique cognitive and physiological ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):